Status:
COMPLETED
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Vaccines
Antiviral Agents
Eligibility:
All Genders
18-120 years
Brief Summary
Background: \- Vaccines and antiviral therapies help prevent and treat diseases. Researchers need a group of healthy volunteers for clinical trials. Clinical trials are studies that test these vaccin...
Detailed Description
Vaccines and antiviral therapies are critical for prevention and treatment of viral diseases. Among other things, testing of vaccines or antiviral medications requires knowing whether the prospective ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age: 18 or older
- Available to participate for the planned duration of at least one clinical trial for which screening is being done or to donate blood, nasal swab, throat swab, and/or urine in support of assay development
- Able and willing to complete the informed consent process
- Agree to have blood and/or urine, stool, nasal swab, or wash samples collected as needed for the clinical trial screening or sample donation process
- Agree to participate in procedures, such as electrocardiogram or pulmonary function tests, as may be needed for the clinical trial screening process
- Do not have plans to become pregnant while on this study
- Able to provide a medical history and other relevant personal information as appropriate
- EXCLUSION CRITERIA:
- A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
- Known to be pregnant or breast-feeding
- If planning to enroll in a clinical trial, the receipt of immunoglobulin within the past 6 months or anticipated within the next year
- Any other condition that in the opinion of the investigator would make the subject unsuitable for enrollment or could interfere with the subject participating in and completing the study or a specimen donation.
- Use of recreational drugs or alcohol dependency or abuse
Exclusion
Key Trial Info
Start Date :
April 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2025
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT02242968
Start Date
April 24 2023
End Date
May 15 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892